Login / Signup

Reporting and social construction of race in Alzheimer's disease clinical trials.

William T Hu
Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)
Keyphrases
  • clinical trial
  • healthcare
  • cognitive decline
  • mental health
  • adverse drug
  • phase ii
  • open label
  • study protocol
  • double blind